Ritulasta 100 mg Injection
$88,40
$68,95
Ritulasta 100 mg injection is a specialized monoclonal antibody designed to target and treat various immune system-related disorders, particularly certain forms of cancer such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. This innovative medication works by precisely binding to specific proteins on the surface of cancer cells, thereby inhibiting their growth and promoting the body’s immune response to eliminate these malignant cells. Patients receiving Ritulasta should be aware of potential side effects, including infusion reactions and infections, making it crucial to monitor their health closely during treatment. This therapy is typically administered under the supervision of a healthcare professional to ensure safety and efficacy. As an essential part of targeted cancer therapies, Ritulasta offers hope for patients battling these challenging conditions. Always discuss with your doctor any underlying health issues or medications you are taking before starting treatment with Ritulasta. By understanding how Ritulasta works and the importance of adherence to prescribed guidelines, patients can better navigate their cancer treatment journey.
數量
Active Pharmaceutical Ingredient
Uses
• Ritulasta 100 mg injection is primarily used in the treatment of non-Hodgkin lymphoma (NHL). This medication helps target and reduce the growth of cancerous cells in the lymphatic system. Patients receiving Ritulasta 100 mg injection can experience improved management of their condition. It is commonly administered as part of a comprehensive treatment plan.
• Another important use of Ritulasta 100 mg injection is in managing rheumatoid arthritis. This condition is characterized by chronic inflammation of the joints, leading to pain and disability. Ritulasta 100 mg injection works by modulating the immune response, helping to alleviate symptoms and improve joint function. It is often used when other treatments are ineffective or not tolerated.
• Ritulasta 100 mg injection is also effective for individuals with chronic lymphocytic leukaemia (CLL). This type of blood cancer affects the bone marrow and blood, leading to an accumulation of dysfunctional lymphocytes. By administering Ritulasta 100 mg injection, healthcare providers aim to reduce the number of abnormal cells in the bloodstream. This contributes to better disease management and improved quality of life for patients.
• Additionally, Ritulasta 100 mg injection is utilized in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis. These conditions involve inflammation of blood vessels, which can affect various organs. The use of Ritulasta 100 mg injection helps to control the inflammatory process, providing relief from symptoms. This targeted approach is crucial in managing these complex autoimmune disorders.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Ritulasta 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Ritulasta 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Ritulasta 100 Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Ritulasta 100 mg Injection is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Ritulasta 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Ritulasta 100 mg Injection can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Ritulasta 100 Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Ritulasta 100 mg. Please consult your doctor.
• Kidney: Ritulasta 100 mg Injection is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Ritulasta 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Ritulasta 100 mg Injection is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Ritulasta 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Ritulasta 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.